By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corcept Therapeutics Inc. 

149 Commonwealth Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-327-3270 Fax: 650-327-3218



Company News
Corcept Therapeutics Inc. (CORT) Appoints Daniel Swisher To Board Of Directors 6/22/2015 12:24:17 PM
Quotient Clinical Delivers Breakthrough First-In-Human Program For Corcept Therapeutics Inc. (CORT) 6/10/2015 8:51:37 AM
Corcept Therapeutics Inc. (CORT) Announces Poster Presentations On Mifepristone For The Treatment Of Patients With Cushing's Syndrome At The 27th Annual American Association of Clinical Endocrinologists 5/15/2015 11:31:15 AM
Corcept Therapeutics Inc. (CORT)' Mifepristone Combined With Eribulin To Improve Antitumor Activity In Patients With Triple-Negative Breast Cancer 5/14/2015 10:57:45 AM
Corcept Therapeutics Inc. (CORT) Announces First Quarter 2015 Results And Provides Corporate Update 5/8/2015 9:55:31 AM
Corcept Therapeutics Inc. (CORT) To Announce First Quarter Financial Results And Corporate Update And Host Conference Call 5/1/2015 11:24:36 AM
Corcept Therapeutics Inc. (CORT) Release: Warrant Exercises Generate $17.2 Million; Proceeds To Advance Next-Generation Compounds And Support Commercialization Of Korlym 4/3/2015 9:59:48 AM
Corcept Therapeutics Announces Nine Poster Presentations On Mifepristone For The Treatment Of Cushing's Syndrome At The 97th Annual Corcept Therapeutics Inc. (CORT) Meeting 3/6/2015 11:00:04 AM
Corcept Therapeutics Inc. (CORT) Announces 2014 Financial Results And Provides Clinical Update 3/5/2015 12:52:58 PM
Corcept Therapeutics Inc. (CORT) Announces Fourth Quarter And Full Year 2014 Revenue, Provides 2015 Revenue Guidance And Clinical Update 1/30/2015 10:56:07 AM